Balloon-Expandable Pulmonary Valves for Patched or Native Right Ventricular Outflow Tracts.
Anchoring technique
Balloon-expandable valves
Congenital heart disease
Percutaneous pulmonary valve implantation
Tetralogy of Fallot
Journal
Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
01
02
2023
accepted:
19
04
2023
medline:
28
6
2023
pubmed:
6
5
2023
entrez:
5
5
2023
Statut:
ppublish
Résumé
The implantation of percutaneous balloon expandable valves in native or patched right ventricular outflow tracts (nRVOT) is a challenging technique due to the diversity of anatomies and shapes, the large sizes, and the distensibility of the nRVOT, for which specific techniques have been developed. We present a single center experience with balloon expandable percutaneous pulmonary valves in nRVOT, describing the techniques used, complications observed, and a short-mid term follow-up.. This is a single center descriptive study of patients who underwent a percutaneous pulmonary valve implantation in a nRVOT with a balloon expandable pulmonary valve in our center between September 2012 and June 2022.. We implanted successfully 45 valves in 46 patients (20 Sapien and 25 Melody). Tetralogy of Fallot or pulmonary atresia with VSD were the main congenital heart disease (n = 32). All were pre-stented, 18 in a one step procedure. We used a Dryseal sheath in 13/21 Sapien. In 6 patients we used the anchoring technique, 5 with a very large nRVOT and one pyramidal nRVOT. In the 3.5 year follow-up 7 patients developed endocarditis and 3 required a valve redilation, no fractures were observed. PPVI of native RVOT with balloon expandable valves is feasible in a number of selected anatomies, including large or pyramidal nRVOT, using specific techniques, (presenting, LPA anchoring).
Identifiants
pubmed: 37147525
doi: 10.1007/s00246-023-03173-2
pii: 10.1007/s00246-023-03173-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1285-1292Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le Bidois J, Sidi D, Kachaner J (2000) Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. https://doi.org/10.1016/S0140-6736(00)02844-0]
doi: 10.1016/S0140-6736(00)02844-0]
pubmed: 11052583
Boone RH, Webb JG, Horlick E, Benson L, Cao QL, Nadeem N, Kiess M, Hijazi ZM (2010) Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter CardiovascInterv 75:286–294. https://doi.org/10.1002/ccd.22250]
doi: 10.1002/ccd.22250]
Esmaeili A, Khalil M, Behnke-Hall K, Gonzalez YGonzalez MB, Kerst G, Fichtlscherer S, Akintuerk H, Schranz D (2019) Percutaneous pulmonary valve implantation (PPVI) in non-obstructive right ventricular outflow tract: limitations and mid-term outcomes. Transl Pediatr. 8(2):107–113. https://doi.org/10.21037/tp.2019.04.02
doi: 10.21037/tp.2019.04.02
pubmed: 31161077
pmcid: 6514279
Martin MH, Meadows J, McElhinney DB, Goldstein BH, Bergersen L, Qureshi AM, Shahanavaz S, Aboulhosn J, Berman D, Peng L, Gillespie M, Armstrong A, Weng C, Minich LL, Gray RG (2018) Safety and feasibility of melody transcatheter pulmonary valve replacement in the native right ventricular outflow tract: a multicenter pediatric heart network scholar study. JACC Cardiovasc Interv 11(16):1642–1650. https://doi.org/10.1016/j.jcin.2018.05.051 . (Epub 2018 Aug 1 PMID: 30077685)
doi: 10.1016/j.jcin.2018.05.051
pubmed: 30077685
Alvarez-Fuente M, Garrido-Lestache E, Fernandez-Pineda L, Romera B, Sánchez I, Centella T, Abelleira C, Villagrá S, Tamariz R, Barrios E, Lamas MJ, Gomez R, Del Cerro MJ (2016) Timing of pulmonary valve replacement: how much can the right ventricle dilate before it looses its remodeling potential? Pediatr Cardiol 37(3):601–605. https://doi.org/10.1007/s00246-015-1320-4 . (Epub 2015 Dec 21 PMID: 26687177)
doi: 10.1007/s00246-015-1320-4
pubmed: 26687177
Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, Moons P, Mulder BJM, Oechslin E, Roos-Hesselink JW, Schwerzmann M, Sondergaard L, Zeppenfeld K, ESC Scientific Document Group (2021) ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 42(6):563–645. https://doi.org/10.1093/eurheartj/ehaa554 . (PMID: 32860028)
doi: 10.1093/eurheartj/ehaa554
pubmed: 32860028
Malekzadeh-Milani S, ladoucer M, Cohen S, Iserin L, Boudjemline Y (2014) Results of transcatheter pulmonary valvulation in native or patched right ventricular outflow tracts. Arch Cardiovasc Dis 07:592–8
doi: 10.1016/j.acvd.2014.07.045
Karsenty C, Malekzadeh-Milani S, Fraisse A, Gewillig M, Bonnet D, Aldebert P, Ovaert C, Bouvaist H, Kempny A, Houeijeh A, Petit J, Hascoet S (2020) Right ventricular outflow tract prestenting with AndraStent XXL before percutaneous pulmonary valve implantation. Arch Cardiovasc Dis 113(2):113–120. https://doi.org/10.1016/j.acvd.2019.12.004 . (Epub 2020 Feb 18 PMID: 32081640)
doi: 10.1016/j.acvd.2019.12.004
pubmed: 32081640
Georgiev S, Tanase D, Ewert P, Meierhofer C, Hager A, von Ohain JP, Eicken A (2018) Percutaneous pulmonary valve implantation in patients with dysfunction of a “native” right ventricular outflow tract—Mid-term results. Int J Cardiol 1(258):31–35. https://doi.org/10.1016/j.ijcard.2017.11.091 . (PMID: 29544952)
doi: 10.1016/j.ijcard.2017.11.091
Kenny D, Morgan GJ, Murphy M, AlAlwi K, Giugno L, Zablah J, Carminati M, Walsh K (2019) Use of 65 cm large caliber Dryseal sheaths to facilitate delivery of the Edwards SAPIEN valve to dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv 94(3):409–413. https://doi.org/10.1002/ccd.28409 . (Epub 2019 Aug 13 PMID: 31408262)
doi: 10.1002/ccd.28409
pubmed: 31408262
Couture EL, Labbé BM, DeLarochellière R, Rodés-Cabau J, Paradis J-M (2016) Stuck leaflet after transcatheter aortic valve replacement with a SAPIEN-3 Valve: new valve, old complication. JACC Cardiovasc Interv 9:e133–e135
doi: 10.1016/j.jcin.2016.04.041
pubmed: 27372196
Güzeltaş A, Tanıdır IC, Gökalp S, Topkarcı MA, Şahin M, Ergül Y (2021) Implantation of the Edwards SAPIEN XT and SAPIEN 3 valves for pulmonary position in enlarged native right ventricular outflow tract. Anatol J Cardiol 25(2):96–103. https://doi.org/10.14744/AnatolJCardiol.2020.46024.PMID:33583816;PMCID:PMC8114652
doi: 10.14744/AnatolJCardiol.2020.46024.PMID:33583816;PMCID:PMC8114652
pubmed: 33583816
pmcid: 8114652
Giugno L, Faccini A, Carminati M (2020) Percutaneous pulmonary valve implantation. Korean Circ J 50(4):302–316. https://doi.org/10.4070/kcj.2019.0291.PMID:32157831;PMCID:PMC7067602
doi: 10.4070/kcj.2019.0291.PMID:32157831;PMCID:PMC7067602
pubmed: 32157831
pmcid: 7067602
Ansari MM, Cardoso R, Garcia D, Sandhu S, Horlick E, Brinster D, Martucci G, Piazza N (2015) Percutaneous pulmonary valve implantation: present status and evolving future. J Am Coll Cardiol 66(20):2246–2255. https://doi.org/10.1016/j.jacc.2015.09.055 . (PMID: 26564602)
doi: 10.1016/j.jacc.2015.09.055
pubmed: 26564602
Morgan GJ, Sadeghi S, Salem MM, Wilson N, Kay J, Roth-man A et al (2019) SAPIEN valve for percutaneous transcatheterpulmonary valve replacement without ‘“pre-stenting”’: amulti-institutional experience. Catheter Cardiovasc Interv 93:324–329
doi: 10.1002/ccd.27932
pubmed: 30351525
Sinha S, Aboulhosn J, Asnes J, Bocks M, Zahn E, Goldstein BH et al (2019) Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: a multi-institutional experience. Catheter Cardiovasc Interv 93(455–63):29
Cardoso R, Ansar M, Garcia D et al (2016) Prestenting for prevention of melody valve fractures: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 87(3):534–539
doi: 10.1002/ccd.26235
pubmed: 26481871